These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35527995)

  • 1. Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
    Gomes MB; Tang F; Chen H; Cid-Ruzafa J; Fenici P; Khunti K; Rathmann W; Shestakova MV; Surmont F; Watada H; Medina J; Shimomura I; Saraiva GL; Cooper A; Nicolucci A
    Front Endocrinol (Lausanne); 2022; 13():831676. PubMed ID: 35527995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
    Khunti K; Chen H; Cid-Ruzafa J; Fenici P; Gomes MB; Hammar N; Ji L; Kosiborod M; Pocock S; Shestakova MV; Shimomura I; Tang F; Watada H; Nicolucci A;
    Diabetes Obes Metab; 2020 Jan; 22(1):66-78. PubMed ID: 31468637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
    Bonnet F; Chen H; Cooper A; Gomes MB; Ji L; Leigh P; Ramirez L; Shestakova MV; Shimomura I; Siddiqui A; Tang F; Vora J; Watada H; Khunti K
    Diabetes Obes Metab; 2021 Oct; 23(10):2336-2343. PubMed ID: 34212481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study.
    Bongaerts B; Arnold SV; Charbonnel BH; Chen H; Cooper A; Fenici P; Gomes M; Ji L; Khunti K; Kosiborod M; Medina J; Nicolucci A; Shestakova M; Shimomura I; Tang F; Watada H; Rathmann W
    BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33941550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of glycaemic control in patients with type 2 diabetes after metformin failure: Prognostic model derivation and validation using the DISCOVER study.
    Ling S; Sun P; Zaccardi F; Khosla S; Cooper A; Fenici P; Khunti K
    Diabetes Obes Metab; 2020 May; 22(5):828-837. PubMed ID: 31944528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-awareness of HbA1c and its association with glycemic control among patients with type 2 diabetes: A multicenter study.
    Almutairi JS; Almigbal TH; Alruhaim HY; Mujammami MH; AlMogbel TA; Alshahrani AM; Al Zahrani AM; Batais MA; Shaik SA
    Saudi Med J; 2022 Mar; 43(3):291-300. PubMed ID: 35256497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of glycemic control in type 2 diabetes mellitus in Brazil: A sub-analysis of the longitudinal data from the BrazIian type 1 & 2 diabetes disease registry (BINDER).
    Moreira RO; Vianna AGD; Ferreira GC; de Paula MA
    Prim Care Diabetes; 2022 Aug; 16(4):562-567. PubMed ID: 35527171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor glycemic control in type 2 diabetes in the South of the Sahara: the issue of limited access to an HbA1c test.
    Camara A; Baldé NM; Sobngwi-Tambekou J; Kengne AP; Diallo MM; Tchatchoua AP; Kaké A; Sylvie N; Balkau B; Bonnet F; Sobngwi E
    Diabetes Res Clin Pract; 2015 Apr; 108(1):187-92. PubMed ID: 25697633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes.
    Innes CWD; Henshall DE; Wilson B; Poon MTC; Morley SD; Ritchie SA
    Diabet Med; 2022 Oct; 39(10):e14902. PubMed ID: 35716029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Intensive Glycemic Management in Older Adults with Diabetes Mellitus.
    Arnold SV; Lipska KJ; Wang J; Seman L; Mehta SN; Kosiborod M
    J Am Geriatr Soc; 2018 Jul; 66(6):1190-1194. PubMed ID: 29633237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of fear of hypoglycemia with second-line use of insulin secretagogues or insulin and subsequent glycemic control in patients with type 2 diabetes: An analysis using data from the DISCOVER study.
    Wang JS; Chen H; Tang F; Sheu WH
    Int J Clin Pract; 2020 Jun; 74(6):e13485. PubMed ID: 32003099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II).
    Weng J; Zhao J; Zhou Z; Guo X; Zou D; Ji Q; Tong N; Li Q; Zhu J; Li Q; Qin G; Feng P; Yang L; Gao Z; Chen L; Li H; Li Y; Zeng L; Zhu D; Lu J; Luo T; Cui N
    J Diabetes; 2020 Jan; 12(1):66-76. PubMed ID: 31222955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study.
    Abera RG; Demesse ES; Boko WD
    BMC Endocr Disord; 2022 Mar; 22(1):54. PubMed ID: 35249547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
    Ji L; Bonnet F; Chen H; Cooper A; Hammar N; Leigh P; Luporini Saraiva G; Ramirez L; Medina J; Nicolucci A; Rathmann W; Shestakova MV; Surmont F; Tang F; Watada H;
    Diabetes Res Clin Pract; 2021 Aug; 178():108947. PubMed ID: 34252505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level of glycemic control among US type 2 diabetes mellitus patients on dual therapy of metformin and sodium-glucose cotransporter 2 inhibitor: a retrospective database study.
    Lautsch D; Iglay K; Yang L; Bansal N; Markan R; Kathe N; Rajpathak S
    Curr Med Res Opin; 2020 Oct; 36(10):1583-1589. PubMed ID: 32866052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.